Hoboken, NJ, United States of America

Zaruhi Hovhannisyan

This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zaruhi Hovhannisyan. Retrieved from https://idiyas.com/inventor/zaruhi-hovhannisyan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zaruhi Hovhannisyan: Innovator in Genetic Research

Introduction

Zaruhi Hovhannisyan is a notable inventor based in Hoboken, NJ (US). She has made significant contributions to the field of genetic research, particularly in developing models for studying skin inflammation disorders.

Latest Patents

Hovhannisyan holds 1 patent for her work on a genetically modified rodent model. This patent focuses on a loss of function mutation in the endogenous Crnn (cornulin) gene. The genetically modified rodent serves as a valuable model for researching skin inflammation disorders, such as psoriasis.

Career Highlights

Zaruhi Hovhannisyan is currently employed at Regeneron Pharmaceuticals, Inc. Her work at this leading biotechnology company allows her to further her research and contribute to advancements in medical science.

Collaborations

Some of her notable coworkers include Claudia Gonzaga-Jauregui and Sokol Haxhinasto. Their collaboration enhances the research environment and fosters innovation within their projects.

Conclusion

Zaruhi Hovhannisyan's contributions to genetic research and her innovative patent demonstrate her commitment to advancing medical science. Her work continues to impact the understanding of skin inflammation disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…